Royal Australian Navy - 👉 Bachelor of Electronic and Communications Engineering
Releaf, Business Of Cannabis, CPD, Cannabis Now Magazine, High Times, Cookies Seeds, Fast Buds, MSNL, Paradise Seeds, Premium Cultivars
Sam North is a content writer at Releaf, specialising in medical cannabis, digital health, and patient education within a UK regulatory framework. After a decade immersed in the cultivation side of the cannabis industry, Sam moved into digital in 2020. He worked across the recreational space with seed companies, CBD brands, and cannabis publications, before transitioning into the medical cannabis sector in early 2023 and joining Releaf in April of that year. Today, his work spans both content and SEO, with a focus on how the two support patient understanding and long-term organic growth. He writes and shapes educational content, research breakdowns, and patient-facing web copy, ensuring it is clear, clinically accurate, and aligned with UK compliance requirements. At Releaf, Sam’s focus is on making medical cannabis more understandable and accessible to patients, while maintaining a high standard of accuracy, compliance, and trust.
Medical cannabis is emerging as a potential treatment for multiple sclerosis symptoms like pain, spasticity, poor sleep, and fatigue. In this blog, we focus on a recent study from the United States examining how cannabinoids may support MS symptom management. We also break down how UK patients can legally access treatment and what a personalised Releaf prescription typically looks like.
Can cannabis really help with period pain? We break down a 2022 review exploring THC, CBD, and the science behind medical cannabis for menstrual cramps.
Releaf’s doctors, nurses, and specialists share why they decided to get involved in medical cannabis, reflecting on personal experiences, patient stories, and the limits of conventional treatments. From Oncology to Neurology, Psychiatry, pain management, and nursing, each voice highlights how clear, compassionate prescribing can transform quality of life. Together, their stories show the growing role of medical cannabis in modern healthcare.
Medical cannabis safety is built on personalised prescribing, careful titration, and ongoing clinical oversight. While fatal THC overdoses have never been recorded, taking too much THC can cause uncomfortable side effects. Learn how Releaf’s patient-first approach helps minimise risks and keeps treatment safe and effective.
A new gold-standard study found that a balanced CBD:THC oil may help people with chronic insomnia sleep longer, feel more rested, and function better the next day. With clear improvements in sleep quality, melatonin production, and morning alertness, the findings offer hope for patients who have tried other natural sleep aids without success.
Releaf’s new callback feature means you no longer need to wait on hold. Press the star key while in the queue, and we will save your place and call you back as soon as we are free. It is a simple change designed to give you more time for the things that matter, without missing the support you need from our Patient Support Team.
CBG has been called the mother of all cannabinoids, but could it also be the most versatile? This blog explores new findings from a 2024 clinical review, highlighting how CBG may affect brain health, inflammation, infections, cancer, and pain. The research is still early, but the signals are encouraging, and human trials are now on the horizon.
Most people have heard of CB1 and CB2 receptors, but cannabinoids affect far more than just those two targets. This blog explores the wider network of receptors and brain chemicals that shape how cannabis works in the body. For UK patients, it’s a step toward more informed, personalised treatment.
A new 2025 study from Italy explored the effects of high-THC medical cannabis oil in fibromyalgia patients with gut symptoms like IBS and chronic indigestion. Over six months, most participants saw meaningful relief from pain, fatigue, bloating, and upper GI discomfort. For some, symptom scores dropped to near-remission levels. Here's what the researchers found, and how to know if THC oil could be right for you.
In this article we will look at the different medical conditions and routes of access UK patients can legally obtain a medicinal cannabis prescription through. Releaf recently conducted public surveys and published a report with the data titled Say No To Pain revealing 58.5% of the British population are likely to be unaware of the current medical cannabis laws.
Medical cannabis costs in the UK start from for initial consultations, from £7.99 per gram for medical cannabis strains, and £74.99-£79.99 for THC vapes, with Releaf+ membership reducing overall medical cannabis pricing by up to 20%. This guide explains how medical cannabis costs are structured, what affects pricing, and how to assess whether treatment fits within your budget. Other clinics may have different charges for their services.
ADHD diagnoses are on the rise, and more adults are searching for support that actually works. We spoke to Releaf psychiatrist Dr Imran Ali about what's driving the shift, why access remains a challenge, and how medical cannabis is helping some patients reduce anxiety, improve focus, and feel more in control of their symptoms.
New research from Denmark has uncovered a striking connection between cannabis use disorder (CUD) and schizophrenia, with up to 30% of cases in young men potentially linked to heavy, unregulated recreational use. In this blog, we break down what the study found, how it informs Releaf’s prescribing approach, and why safeguarding vulnerable groups is essential to safe and ethical medical cannabis treatment.
What’s legal, and what isn’t, when it comes to CBD vs THC in the UK? This guide breaks down the legal status of both cannabinoids, explains why THC requires a prescription, and outlines how medical cannabis works for those who qualify. If over-the-counter CBD isn’t enough, there may be a clinically guided, THC containing alternative available.
Can cannabis actually help suppress tumours? From brain and breast cancer to colon and lung models, the lab results are intriguing, but far from conclusive. In this Decoding Cannabis blog, we explore the latest preclinical studies on THC, CBD, and synthetic cannabinoids, compare them with other natural compounds, and share what UK patients battling cancer are prescribed UK medical cannabis for right now.
In the UK, getting a medical cannabis prescription isn’t like popping down to the chemist. This blog breaks down how online cannabis dispensaries actually work, why your meds can take a few days to arrive, and how Releaf ensures safe, consistent delivery every time (even during a snowy Christmas). From regulation to real people, we explain what’s really going on behind the scenes.
Medical cannabis is emerging as a potential treatment for multiple sclerosis symptoms like pain, spasticity, poor sleep, and fatigue. In this blog, we focus on a recent study from the United States examining how cannabinoids may support MS symptom management. We also break down how UK patients can legally access treatment and what a personalised Releaf prescription typically looks like.
Releaf’s educational content is carefully planned, clinically informed, and always human written. In a space flooded with noise, we’ve built a resource that patients trust. From first click until they are fully set up (and beyond), our blog helps people feel informed, understood, and ready to take the next step, and the data shows it works.
The gut does far more than digest. It's a second brain of sorts, wired with nerves, hormones, and immune cells, all working in sync with the microbiome. This blog focuses on new research and explores how cannabinoids interact with that system, drawing from one of the most comprehensive clinical reviews to date, along with real experiences from Releaf patients living with chronic GI conditions.
More than 100,000 people across the UK have completed Releaf’s free medical cannabis eligibility checker and created a secure patient account. This isn’t just a number. It reflects a growing shift in how patients think about their health, and a not-so-quiet turning point in how UK medical cannabis is seen, accessed, and supported.
What mattered most for UK medical cannabis patients in 2025? In this midyear review, we spotlight one Releaf blog per month, covering legality, absorption, stigma, stop and search, and more. Each post is written to inform and empower patients navigating a changing clinical and legal landscape.
Sleep apnoea doesn’t just disrupt breathing, it wrecks rest, energy, and wellbeing. A large US study found that medical cannabis helped many patients manage fatigue and improve sleep quality. In the UK, Releaf offers structured, specialist-guided access to the same kinds of treatments. If CPAP isn’t working, this could be a clinically supported option worth exploring.
With almost 2,000 verified Trustpilot reviews and an average score of 4.7, Releaf is the most trusted medical cannabis clinic in the UK. We provide regulated prescriptions, consistent access to high-quality medication, and a UK-based clinical and support team that actually cares. With unlimited clinical support, personalised treatment, and our custom-built patient platform, we are changing what safe, effective cannabis care looks like in the UK.
A new preclinical study explores whether cannabinoids like CBD, CBG and CBN can directly reduce chronic pain by targeting the sodium channel Nav1.8. The findings suggest these non-psychoactive compounds may help slow pain signalling at its source. In this edition of Decoding Cannabis, we break down what the study found, what it means for patients, and how Releaf is helping lead the change.
"Since starting my treatment plan with Releaf, I’m genuinely shocked at how well it has worked."Chloe Durrington, Releaf patient
